Peritoneal carcinomatosis from a small bowel carcinoid tumour

被引:6
作者
Gutierrez G. [1 ]
Daniels I.R. [2 ]
Garcia A. [1 ]
Ramia J.M. [1 ]
机构
[1] Hospital Universitario Virgen de las Nieves, Granada
[2] Royal Devon and Exeter Hospital, Exeter
关键词
Liver Metastasis; Octreotide; Carcinoid Tumour; Peritoneal Carcinomatosis; Intraperitoneal Chemotherapy;
D O I
10.1186/1477-7819-4-75
中图分类号
学科分类号
摘要
Background: Peritoneal carcinomatosis from a gastrointestinal carcinoid tumour is rare and the long-term management and prognosis have not been clearly defined. The natural history is different from gastrointestinal adenocarcinoma, although its capacity to invade regional lymph nodes and generate distal metastasis can make the management more complex. Whilst the development of carcinomatosis is uncommonly reported, it may be higher than expected. Case presentation: A 63 years-old woman underwent emergency surgery in 1993 for right iliac fossa pain and a mass that was found to be an ileal carcinoid tumour. Over the next ten years, further surgery was required for disseminated disease with peritoneal carcinomatosis and liver metastasis. Systemic chemotherapy had little effect, although Somatostatin was used effectively to relieve symptoms caused by the disseminated disease (flushing and diarrhoea). Conclusion: Peritoneal carcinomatosis from carcinoid tumours is not well documented in the literature. Aggressive surgery must be performed in order to control the disease since chemotherapy has not been reported to be effective. With repeated surgery long-term survival can be achieved in these patients. © 2006 Gutierrez et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 20 条
[1]  
Stunner B., Kicker O., Zilches A., Rothmans M., Surgical management for Carcinold tumours of small bowel, appendix, colon, and rectum, World J Surg, 20, pp. 183-188, (1996)
[2]  
Creutzfeldt W., Carcinoid turnours: Development of our knowledge, World J Surg, 20, pp. 126-131, (1996)
[3]  
Kloppel G., Heitz P.U., Capella C., Solcia E., Pathology and nomenclature of human gastrointestinal neuroendocrine (Carcinoid) tumours and related lesions, World J Surg, 20, pp. 132-141, (1996)
[4]  
Kulke M.H., Mayer R.J., Carcinoid tumours, N Engl J Med, 340, pp. 858-868, (1999)
[5]  
Schnirer I.I., Yao J.C., Ajani J.A., Carcinoid - A comprehensive review, Acta Oncol, 42, pp. 672-692, (2003)
[6]  
Bax N.D., Woods H.F., Batchelor A., Jennings M., Clinical manifestations of carcinoid disease, World J Surg, 20, pp. 142-146, (1996)
[7]  
Godwin J.D., Carcinoid tumors. An analysis of 2,837 cases, Cancer, 36, pp. 560-569, (1975)
[8]  
Maggard M.A., O'Connell J.B., Ko C.Y., Updated population-based review of carcinoid tumours, Ann Surg, 240, pp. 117-122, (2004)
[9]  
Modlin I.M., Sandor A., An analysis of 8305 cases of carcinoid tumours, Cancer, 79, pp. 813-829, (1997)
[10]  
Toth-Fejel S., Pommier R.F., Relationships among delay of diagnosis, extent of disease, and survival in patients with abdominal carcinoid tumours, Am J Surg, 187, pp. 575-579, (2004)